🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a proof-of-concept study to determine if PH-797804 reduces neuropat...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-04
Trial ID
NCT00614705
PH-797804 is an oral ant-inflammatory drug that may reduce the inflammation...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-05
Trial ID
NCT01321463
PH-797804 is a potent inhibitor of inflammatory mediators that have a poten...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-05
Trial ID
NCT01102660
Treatments Being Tested
The hypothesis of this study is that the p38 inhibitor (PH-797804) will be ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-03
Trial ID
NCT00620685
A single dose study with the inhaled anti-inflammatory agent PF-03715455 to...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-01
Trial ID
NCT01314885
Treatments Being Tested
PH-797804 is an oral anti-inflammatory drug that may reduce the inflammatio...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2012-04
Trial ID
NCT01543919
Study A6631027 will evaluate the safety, tolerability and pharmacokinetics ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-10
Trial ID
NCT01217918
Investigating the safety and tolerability of a p38 inhibitor as monotherapy...
Status
Completed
Location
Emeritus Research
Start Date
2006-12-15
Trial ID
NCT00383188